Skip to content
Events

Details

Hear from Steve Barnard about the latest Illumina innovations from library prep, sequencing, and analysis and learn how we are enabling transformative applications using multiomics. Niall Lennon, PhD from the Broad Institute of MIT will join Steve to provide insights into new Illumina technology.
Steve Barnard, PhD

Steve Barnard, PhD
Chief Technology Officer
Illumina

Steve Barnard, PhD

Niall Lennon, PhD
Chair and Chief Scientific Officer
Broad Clinical Labs, MIT

 

M-AMR-01684
Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
6 Nov. 2024
Topic
Instruments, Software & informatics
Watch Now

Related Events

Mar 19
GenomeStudio - Creating Custom Cluster Files
Mar 19, 2025
Using GenomeStudio software to generate custom cluster files is necessary to analyse custom microarray content. In this webinar, we discuss the basics of cluster files including when to use a custom cluster file, why custom cluster files are needed, as well as the detailed steps required to create your own custom cluster file. Learn how to cluster the SNPs on your custom array by properly filtering and manually editing the file.
View Event
Mar 20
Remarkably simple sequencing for infectious disease and microbiology research
Mar 20, 2025
Discover how the MiSeq i100's breakthrough innovations translate into real-world benefits for your infectious disease surveillance and microbiology research. This webinar, designed for both experienced Next-Generation Sequencing (NGS) users and newcomers, will show you how the MiSeq i100 can optimize workflows, expand research capabilities, and provide a seamless entry into the world of genomics. Unlock new possibilities with MiSeq i100 and Illumina’s integrated Infectious disease and microbiology solutions.
View Event
Mar 23
ABRF Annual Meeting 2025
Mar 23, 2025 – Mar 26, 2025
Visit Illumina booth #200/202 at ABRF to network and learn more about our sequencing instruments, arrays, product releases, and trade-in offers. ​ ​
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.